The role of microbiota and its modulation in colonic diverticular disease
Neurogastroenterology & Motility · 2023-12 · 35 (12)
DOI: 10.1111/nmo.14615 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neurogastroenterology & Motility, online erschienen am 27.05.2023. Verfasst von Giovanni Marasco und 5 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Probiotics, Diverticulosis, Colonic, Diverticular Diseases, Microbiota. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fondazione Carisbo, Fondazione del Monte di Bologna e Ravenna, Horizon 2020 Framework Programme.
Abstract (Originalsprache)
Background
Diverticular disease (DD) is a common condition in Western countries. The role of microbiota in the pathogenesis of DD and its related symptoms has been frequently postulated since most complications of this disease are bacteria‐driven and most therapies rely on microbiota modulation. Preliminary data showed fecal microbial imbalance in patients with DD, particularly when symptomatic, with an increase of pro‐inflammatory and potentially pathogenetic bacteria. In addition, bacterial metabolic markers can mirror specific pathways of the disease and may be even used for monitoring treatment effects. All treatments currently suggested for DD can affect microbiota structure and metabolome compositions.
Purpose
Sparse evidence is available linking gut microbiota perturbations, diverticular disease pathophysiology, and symptom development. We aimed to summarize the available knowledge on gut microbiota evaluation in diverticular disease, with a focus on symptomatic uncomplicated DD, and the relative treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Department of Medical and Surgical Science, University of Bologna, Bologna, Italy.
ORCID-Profile: Giovanni Marasco, Cesare Cremon, Maria Raffaella Barbaro, Vincenzo Stanghellini, Giovanni Barbara
Förderung
- Fondazione Carisbo
- Fondazione del Monte di Bologna e Ravenna
- Horizon 2020 Framework Programme
- Italian Ministry of Health
- Ministero della Salute
Zitieren
APA
Marasco, G., Buttitta, F., Cremon, C., Barbaro, M. R., Stanghellini, V., & Barbara, G. (2023). The role of microbiota and its modulation in colonic diverticular disease. Neurogastroenterology & Motility, 35(12). https://doi.org/10.1111/nmo.14615
Vancouver
Marasco G, Buttitta F, Cremon C, Barbaro MR, Stanghellini V, Barbara G. The role of microbiota and its modulation in colonic diverticular disease. Neurogastroenterology & Motility. 2023;35(12). doi:10.1111/nmo.14615
BibTeX
@article{Marasco2023,
author = {Marasco, Giovanni and Buttitta, Francesco and Cremon, Cesare and Barbaro, Maria Raffaella and Stanghellini, Vincenzo and Barbara, Giovanni},
title = {The role of microbiota and its modulation in colonic diverticular disease},
journal = {Neurogastroenterology & Motility},
year = {2023},
volume = {35},
number = {12},
doi = {10.1111/nmo.14615}
}
EUVIMED